In a 10-to-3 vote by the Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee (FDA PADAC), Boehringer Ingelheim Pharmaceuticals, Inc.’s investigational nasal spray tiotropium bromide has been recommended for approval ... Read more